UPDATE 2-FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound

Retrieved on: 2024-03-06 17:53:29

Tags for this article:

CYP3A4 inhibitors

COVID-19 drug development

COVID-19 vaccination in the United States

Nirmatrelvir/ritonavir

Pfizer

Food and Drug Administration

Antiviral drug

u.s. food and drug administration

Click the tags to see associated articles and topics

UPDATE 2-FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound. View article details on HISWAI: https://ca.movies.yahoo.com/movies/1-fda-asks-pfizer-test-201939904.html

Excerpt

The U.S. Food and Drug Administration (FDA) has asked Pfizer Inc to test the effects of an additional course of its antiviral Paxlovid among ...

Article found on: ca.movies.yahoo.com

View Original Article